DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The "Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Workflow (Discovery, Development), By Mode (In-house, Outsourced), By Services, By Region, Vendor Landscape, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global drug discovery informatics market size is expected to reach USD 2.07 billion by 2025, progressing at a CAGR of 12.6% during the forecast period. Drug therapy is evolving in response to health care needs of the population. The most recent trend is to develop drugs for treatment of chronic diseases, especially those affecting the older population.

Cardiovascular Diseases (CVDs), stroke, and cancer are the most prevalent health issues and also the most common conditions causing death. Moreover, treatment expenses and costs pertaining to these diseases are very high, which triggers the demand for effective novel molecules. In the U.S. alone, revenue generated through CVD treatments was over USD 444 billion in 2010, and it has been estimated to claim more lives each year than the remaining causes of death combined.

Clinical decision support tools, which include online database for assistance in enhancement of clinical decisions, are timely updated and that significantly impacts market growth. Moreover, the World Health Organization's Consultative Expert Working Group for Research and Development is also involved in evaluation and development of open source drug discovery platforms. Introduction of open drug discovery tool kit (ODDT), which serves as a tool for computer-aided drug discovery by implementing machine learning scoring functions (RF-Score and NN-Score), is anticipated to work in favor of the market.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Drug Discovery Informatics Industry Outlook

Chapter 4 Drug Discovery Informatics Workflow Outlook

Chapter 5 Drug Discovery Informatics Mode Outlook

Chapter 6 Drug Discovery Informatics Service Outlook

Chapter 7 Drug Discovery Informatics Regional Outlook

Chapter 8 Competitive Landscape

PerkinElmer, Inc.Thermo Fisher Scientific, Inc.Certara, L.P.NOVO INFORMATICS PVT. LTDCollaborative Drug Discovery Inc.Jubilant Life Sciences LimitedSelvitaCharles River Laboratories International, Inc.ChemBridge CorporationAlbany Molecular Research Inc. (AMRI)GVK Biosciences Private Limited,Infosys Ltd.For more information about this report visit https://www.researchandmarkets.com/research/5fbvkp/global_drug?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005327/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/06/2018 04:12 AM/DISC: 09/06/2018 04:12 AM

http://www.businesswire.com/news/home/20180906005327/en